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OBJECTIVES The purpose of this study was to investigate the phenomenon of left ventricular (LV)
dysfunction after ultraendurance exercise.
BACKGROUND Subclinical LV dysfunction in response to endurance exercise up to 24 h duration has been
described, but its mechanism remains elusive.
METHODS We tested 86 athletes before and after the Adrenalin Rush Adventure Race using echocardiog-
raphy, impedance cardiography, and plasma immunoassay.
RESULTS At baseline, athletes demonstrated physiology characteristic of extreme endurance training.
After 90 to 120 h of almost-continuous exercise, LV systolic and diastolic function declined
(fractional shortening before the race, 39.6  0.65%; after, 32.2  0.84%, p  0.001; mitral
inflow E-wave deceleration time before the race, 133  5 ms; after, 160  5 ms, n  48,
p  0.001) without change in loading conditions as defined by LV end-diastolic dimension
and total peripheral resistance estimated by thoracic impedance. There was a compensatory
increase in heart rate (before, 55 1.3 beats/min; after, 59 1.5 beats/min, p 0.05), which
left cardiac output unchanged, as well as significant-but-subclinical increases in brain
natriuretic peptide and troponin I. In addition, we found that athletes who were homozygous
for the intron-16 insertion polymorphism of the angiotensin-converting enzyme (ACE) gene
exhibited a significantly greater decrease in fractional shortening than athletes who were
homozygous for the deletion allele. Heterozygotes showed an intermediate phenotype. In
addition, the deletion group manifest an enhanced sympathovagal balance after the race, as
evidenced by greater power in the low-frequency component of blood pressure variability.
CONCLUSIONS The ACE genotype predicts the extent of reversible subclinical LV dysfunction after
prolonged exercise and is associated with a differential postactivity augmentation of sympa-
thetic nervous system function that may explain it. (J Am Coll Cardiol 2006;48:523–31)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.02.071© 2006 by the American College of Cardiology Foundation
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ihroughout history, humans have pushed themselves to
heir physical limits. Although skeletal muscle fatigue is well
ecognized and characterized, cardiac fatigue is relatively
ew and less well described (1,2). Although Saltin and
tenberg (3) made reference to exercise induced cardiac
ysfunction, Douglas et al. (2,4,5) characterized the phe-
omenon through a series of studies on athletes participat-
ng in the Hawaii Ironman. This multidiscipline triathlon
omprises a 2.4-mile swim, a 112-mile bike race and a
6.2-mile run, representing 8 to 17 h of continuous exercise.
fter prolonged exercise, athletes were found to exhibit
ystolic and diastolic right and left ventricular (LV) dysfunction
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ardiovascular Diseases and Cardiology Division, Duke University Medical Center,
urham, North Carolina.fi
Manuscript received October 8, 2005; revised manuscript received February 1,
006, accepted February 21, 2006.ith only minimal change in loading conditions (2,4–6).
lthough the balance of evidence was clearly in favor of this
ardiac fatigue, not all authors found similar declines. In
articular, studies examining shorter exercise periods showed
ittle evidence of such dysfunction (7–9), suggesting a threshold
uration of exercise. This hypothesis was supported by the
hyte et al. (10) report which noted changes in fractional
hortening that were significant after full but not half Ironman-
istance events. Several authors have independently described
ardiac “drift,” whereby heart rate (HR) “drifts” upward as
rolonged exercise continues. Although a series of experiments
ave suggested that this phenomenon may be explained by
hermoregulatory processes (11–16), it remains possible that
he increase in HR is a compensatory response to LV dysfunc-
ion. However, the only study to address this found a relation-
hip only with diastolic function (11).
The insertion/deletion polymorphism of intron-16 of the
ngiotensin-converting enzyme (ACE) gene was originally
ound to be associated with increased risk of myocardial
nfarction (17,18). Although this association was not con-
rmed in two subsequent studies (19,20). Montgomery
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ACE Genotype and Prolonged Exercise August 1, 2006:523–31t al. (21) were the first to suggest over-representation of the
nsertion allele in elite mountaineers and, subsequently,
ther groups of aerobic endurance athletes, such as rowers
nd distance runners. Although some inconsistent findings
merged in respect of this “fitness” gene, the elegant follow-up
ork of Montgomery et al. (21) confirmed an important role
or this genomic regulator of ACE activity in fitness and
raining (22). Given the central role of the renin-angiotensin
ystem in LV remodeling, heart failure, and bodily fluid
alance, we hypothesized a differential effect of ACE genotype
n exercise induced LV dysfunction.
ETHODS
thics. The study was approved by the University of
xford Institutional Ethics committee. Each patient gave
nformed written consent. The study was performed accord-
ng to the principles of the Declaration of Helsinki.
drenalin Rush Adventure Race. Adrenalin Rush (now
he British Adventure Racing Championship) is a multidis-
ipline adventure race conducted annually over a distance
f approximately 300 miles in the Scottish highlands or
rish dales. Teams of 4 containing at least 1 member of
he opposite gender race together over the course: trekking,
ountain biking, kayaking, ascending and descending fixed
opes, and swimming. The goal of the competition is to be
he first team across the finish line. The event is designed to
ush human endurance to the limits. In many cases, athletes
ompete for days without rest or sleep.
aseline measurements. Height and weight were measured
n each competitor before and after the race. Skin caliper
ssessment of body fat was conducted by one operator accord-
ng to standard techniques (23). Eighty-six athletes were
onsented and had blood drawn. Fifty-four athletes under-
ent echocardiography before the race, and 48 underwent
chocardiography after the race. Of these, 27 also under-
ent measurements of thoracic impedance, HR variability,
nd blood pressure (BP) variability before and after the race.
ifty-five athletes had repeat blood draws.
chocardiography. Echocardiography was performed by a
ingle operator using the Acuson Cypress machine (0.5 to
.6 MHz phased-array adult cardiac probe). Five beat loops
erived from standard parasternal and apical views were
tored for later offline analysis. Fractional shortening, ejec-
ion fraction, LV mass, and LV mass index were derived
ccording the standard methods recommended by the
Abbreviations and Acronyms
ACE  angiotensin-converting enzyme
BRS  baroreceptor reflex sensitivity
BNP  brain natriuretic peptide
BP  blood pressure
HR  heart rate
LV  left ventricularmerican Society of Echocardiography (24) with leading bdge to leading edge quantification of the left ventricular
avity, posterior wall, and interventricular septum at a
ong-axis position just apical to the mitral valve leaflets in
he parasternal view. Pulsed-wave Doppler assessment of
he transmitral valve blood flow was used to provide a
easurement of LV relaxation. Peak early (E) and atrial (A)
lling velocities were recorded, as well as the deceleration
ime of the early (E) wave. Left atrial size also was measured
n the parasternal long-axis view. These measurements were
onducted before and within 6 h of the end of the race.
mpedance cardiography. We assessed cardiothoracic im-
edance and autonomic function using the Task Force
onitor (CNSystems, Graz, Austria). This integrated sys-
em includes electrocardiogram, impedance cardiography,
eat-to-beat BP, and oscillometric BP recording. Stroke
olume and cardiac output are estimated using impedance
ardiography (25–27). In brief, a constant sinusoidal alter-
ating current I0 of 400 A and 40 kHz is passed through
he thorax between short-band electrodes placed on the neck
nd on the lower thorax aperture. The baseline impedance
Z0) and the maximum rate of change in impedance (dZ/dt)
re used for the estimation of stroke volume by a modification
f the method of Kubicek et al. (28).
P and HR variability. Autonomic parameters were ob-
ained by analysis of HR and BP variability derived from
etected R-R intervals in the ECG and continuous BP
onitoring. An adaptive autoregressive model based on a
ecursive least-squares algorithm is used to estimate power
pectral density. Time-variant autoregressive coefficients are
etermined by adaptive parametric identification, which
btains weighted values of a sliding exponential window
ith a history of 60 beats. Absolute power in the very
ow-frequency (0.003 to 0.04 Hz), low-frequency (0.04 to
.15 Hz), and high-frequency (0.15 to 0.4 Hz) bands are
alculated according to the European Society of Cardiology
ask Force recommendations (26).
Spontaneous baroreceptor activity is determined using
he sequence method, which detects increasing sequences
increasing systolic BP, longer RR interval) and decreasing
equences (decreasing systolic BP, shorter RR interval) from
he continuous beat-to-beat measurement of RR interval and
ystolic BP. If 3 or more consecutive beats show an increase (or
ecrease) of systolic BP (1 mm Hg per beat), a BP “ramp” is
etected. If this ramp is matched by an increase (or decrease) of
4 ms in the RR interval, a baroreceptor sequence “event” is
etected. Sequences with an increase of BP and RR interval are
alled baroreceptor “up” sequences, whereas sequences with a
ecrease of BP and RR interval are called baroreceptor “down”
equences. Baroreceptor reflex sensitivity (BRS) is then com-
uted as follows:
BRS
RRI
Sys  msmm Hg
he baroreceptor effectiveness index (BEI) is the ratio of
aroreceptor sequences to the number of BP ramps:
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No. of sequences
No. of ramps
%
lasma markers. Blood was drawn using a standard
acutainer system. One sample was immediately frozen as
hole blood, and a second was centrifuged after clotting.
erum supernatant was pipetted into a plain Eppendorf
or later assessment of electrolytes and cardiac troponin I.
third blood sample was collected in an ethylene
iamine tetraacetic acid tube, spun down, and the plasma
upernatant pipetted into a second Eppendorf tube con-
aining a protease inhibitor. This second sample was used
or measurement of brain natriuretic peptide (BNP). The
ssessment of blood electrolytes was conducted using a
tandardized clinical system. Cardiac troponin I and
NP were quantified using standard enzyme immunoas-
ay kits (Troponin I: AccuTnI assay, Beckman Coulter,
ullerton, California, lower limit of detection of troponin
as 0.01 g/l; BNP: Bayer, Newbury, United Kingdom,
ower limit of detection 0.6 pmol/l).
enotyping of the ACE locus. One blood sample was
tored and deoxyribonucleic acid extracted from 200 l of
hole blood using the Qiagen DNA mini kit (Qiagen,
rawley, United Kingdom). Genotyping for the insertion/
eletion polymorphism (intron 16) of the ACE gene was
onducted using the 3 primer method of Humphries
ACE1: CAT CCT TTC TCC CAT TTC TC; ACE2:
GGGATTACAGGCGTGATAC; ACE3: ATTTCA-
AGCTGGAATAAAA) (29). Primer ratios correspond to
he 50-pmol ACE1 and 3- and 15-pmol ACE2 used in a
0-l reaction, giving amplification products of 84 bp for allele
CE D and 65 bp for allele ACE I. We used touchdown
ycling for amplification: 1 cycle at 95°C for 2 min; 10 cycles of
5°C for 30 s, 62°C for 30 s, 72°C for 2 min followed by 20
ycles of 95°C for 30 s, 57°C for 30 s, and 72°C for 2 min,
ollowed by a final 10-min hold at 72°C. This method yields
mplification products of 65 bp (I allele) and 84 bp (D
llele). Products were separated by electrophoresis on a 3%
garose ethidium bromide gel.
ata analysis. Data were analyzed using NCSS (NCSS,
aysville, Utah). A three-by-two (genotype  pre/post)
epeated-measures analysis of variance was used. Exact
values for pre-post main effects are reported except where
genotype main effect or an interaction is specifically noted.
ecause there were a large number of samples with below
etection levels of troponin and BNP, these data were coded
s categorical (0  undetectable, 1  detectable) and
ncluded in the general linear model.
ESULTS
articipant and race demographics. Participants in the
ace were in teams of 4, with each team including at least
ne member of the opposite gender. The group was highly
iverse and ranged from national class elite athletes with
ody fat percentages as low as 6% and resting HRs as low as d8 beats/min to recreational athletes (Table 1). The race was
onducted over approximately 300 miles of Scottish coun-
ryside and involved the following disciplines: trekking,
unning, cycling, kayaking, swimming, rope maneuvers such
s abseiling, and horse riding. The leaders completed the
ace in 84 h, 7 min, and the last team tested crossed the line
ore than 24 h later at 109 h, 58 min. Most teams slept
pproximately 2 h per night, with a small number of
ompetitors sleeping up to 4 h per night.
emodynamics and LV function. Baseline echocardiog-
aphy demonstrated characteristics typical for endurance
thletes (Table 2, Fig. 1) and similar to those found in
revious studies (30,31). Continuous HR monitoring was
onducted in a small number of competitors during the race
n  8, Fig. 1E) and demonstrated consistent and sustained
achycardia, in some cases with mean HRs 100 beats/min
or 100 h. After the race, significant decrements were noted
n systolic and diastolic function in the absence of changes
n loading conditions (Fig. 1, LV end diastolic diameter,
 0.19; mean arterial pressure p  0.5). Total peripheral
esistance showed a downward trend (p  0.09) whereas
R was slightly higher after the race (p  0.05). Despite
hese changes, which would tend to augment ventricular
unction, systolic function measured by fractional shorten-
ng declined by 7.43% (p  0.0001). In addition, the
eceleration time of the early (E) wave increased significantly
 27 ms; p 0.001). The left atrial diameter was also mildly
ut significantly greater after the race ( 0.17 cm; p  0.02).
In the subset of competitors who underwent impedance
ardiography, stroke volume did not change (Table 3).
owever, base impedance was significantly decreased after
he race (2.6 ohms, p  0.001), and the rapid ejection
eriod (time from opening of aortic valve to maximum rate
f change of impedance) was increased (0.005 ms; p 
.001), which is consistent with a more sluggish LV
jection.
Resources did not allow us to scan a large number of
ompetitors at time points distant from the end of the race.
owever, we did have the opportunity to rescan one of the
op teams at both 24 and 48 h (n  4) (Fig. 2A). In these
ompetitors, partial recovery of the systolic function was
able 1. Demographic Characteristics of the Athletes (Men,
 62; Women, n  23)
Mean SEM
ge (yrs) 34 5
eight (kg) 74.6 1.2
eight (cm) 177.7 0.8
SA (m2) 1.91 0.025
at % by skin caliper 19.9 0.56
VPW (diastole, cm) 1.2 0.03
VS (diastole, cm) 1.37 0.04
V mass (g) 322.53 9.43
V mass index (g/m2) 168.51 5.59
SA  body surface area; IVS  inter ventricular septum; LV  left ventricular;
VPW  left ventricular posterior wall.emonstrated at 48 h. The decrements in systolic function
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ACE Genotype and Prolonged Exercise August 1, 2006:523–31bserved were greater than those previously reported (Fig.
B).
utonomic function. Markers of autonomic function were
erived from beat-to-beat measurement of RR interval and
P. Resolving small changes in the frequency domain by
ourier analysis leads to derivation of components tradition-
lly recognized to represent sympathovagal activation. We
aw changes in several components of these frequency
omains as well as in total power (Table 4). The more
onsistent results were found in BP variation when normal-
zed to total power. Specifically, the very low frequency
omponent was diminished (p  0.001) whereas the low-
nd high-frequency components were increased (p  0.07
nd p  0.03, respectively). Very low frequency components,
hich are thought to relate to humoral or thermoregulatory
nfluences, were changed in both HR variability (increased,
long with the total power, p  0.02 and p  0.04, respec-
ively) and BP variability (decreased, p  0.001).
The spontaneous activity of the baroreceptor reflex is
stimated by increasing or decreasing sequences if sustained
ver three beats or more. The quantity of sequences sus-
ained over three beats or more (“ramps”) was little changed
fter the event, but the when the number of sequences were
xpressed as a function of the number of ramps (the
aroreceptor effectiveness index) a significant increase was
ound (p  0.02).
lasma markers. Plasma levels of electrolytes were normal
n athletes before the race. After the event, plasma potas-
Table 2. Echocardiography (n  54) and Bloo
the Race
Before S
LVEDD, (cm) 5.12 0
LVESD, (cm) 3.09 0
Fractional shortening, (%) 39.63 0
Ejection fraction, (%) 77.52 0
HR, (beats/min) 55 1
SBP (mm Hg) 124 1
DBP (mm Hg) 73 1
MAP (mm Hg) 91 1
Mitral E peak (m/s) 0.86 0
Mitral A peak (m/s) 0.42 0
Mitral Edecel (ms) 133 5
Left atrium (cm) 3.93 0
Sodium (mmol) 138 0
Potassium (mmol) 4.2 0
Urea (mmol) 5.5 0
Creatinine (mmol) 83.6 1
Calcium (mmol) 2.3 0
Magnesium (mmol) 0.87 0
Albumin (mmol) 44.4 0
ALT (mmol) 9.80 0
AST (mmol) 14.0 3
LDH (mmol) 132.6 4
CK (mmol) 108 7
*Indicates a p value 0.05.
ALT alanine aminotransferase; AST aspartate amino
HR  heart rate; LDH  lactate dehydrogenase; LVEDD 
end systolic diameter; MAP  mean arterial pressure; SBPium was reduced (Table 2, p  0.0001). Both calcium and Hlbumin were significantly lower (p 0.001, the latter could
ause the former). Other markers of liver function, as well as
reatine kinase (1,250 mmol) were highly significantly
ncreased after the race. Although most athletes had unde-
ectable levels of troponin I both before and after the race,
significantly greater proportion had detectable levels af-
erwards (detectable range before the race, 7 of 54 [13%];
fter the race, 22 of 54 [41%] p  0.0001). One athlete had
troponin level in the clinical range (0.36), which was
ssociated with a 24% decrease in fractional shortening, a
4-ms increase in time Edecal, a 528-mmol increase in creatine
inase, and the appearance of incomplete right bundle branch
lock. This athlete was the only one to have an after-race
jection fraction in the pathological range (45%).
Most athletes had undetectable levels of BNP before the
ace (13 of 54 detectable, 24%), but a much greater
roportion were in the detectable range after the race (48 of
4, 89%; mean level 6.5  0.66 with a peak of 20.4 pmol/l;
 0.0001). No competitor had a BNP level in the
athological range.
ffect of ACE genotype. The ACE genotype was distrib-
ted in a fashion consistent with the Hardy-Weinberg
quilibrium (DD genotype 31%, II genotype 23%, ID
eterozygotes 46%). There was no excess of the I allele in
his population, as has been previously reported in moun-
aineers (21). In addition, we found no effect of ACE
enotype on LV mass or LV mass corrected for body surface
rea, as has been described in clinical populations (Fig. 3B).
emistry (n  55) Analysis Before and After
After SEM p Value
5.05 0.06 0.19
3.43 0.06 0.0001*
32.20 0.84 0.0001*
67.92 1.18 0.0001*
59 1.5 0.05
127 2.0 0.09
73 1.3 0.8
92 1.3 0.52
0.90 0.02 0.2
0.45 0.02 0.6
160 5 0.001*
4.10 0.05 0.02
138 0.3 0.8
3.7 0.04 0.0001*
5.5 0.24 0.8
81.2 1.4 0.06
2.1 0.01 0.001*
0.87 0.001 0.6
41.7 0.36 0.001
24.0 2.40 0.0001
70.0 7.5 0.0001
320 15.7 0.0001
1358 181.2 0.0001
rase; CK creatine kinase; DBP diastolic blood pressure;
vertricular end diastolic diameter; LVESD  left vertricular
olic blood pressure.d Ch
EM
.07
.07
.65
.71
.3
.5
.3
.3
.03
.02
.07
.6
.04
.16
.9
.02
.001
.73
.48
.6
.9
.4
transfeowever, the ACE genotype did predict a differential decline
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August 1, 2006:523–31 ACE Genotype and Prolonged Exercisen systolic function as measured by fractional shortening and
jection fraction. Specifically, competitors homozygous for the
nsertion allele had a significantly greater decline than those
omozygous for the deletion allele (Fig. 3A, p  0.017).
eterozygotes fell in an intermediate range. No such
ifferential effect was found for diastolic function. In addi-
ion, there was no association of genotype with possible
onfounders such as exercise time. We found that ACE
enotype also predicted differential effects in autonomic
unction (Fig. 4). Specifically, the low-frequency domain of
PV increased dramatically in DD genotype individuals
fter the race whereas those with II or ID genotypes showed
ittle change (p  0.06). In a similar fashion, a significant
ecline the high-frequency domain was observed only in
igure 1. Echocardiographic and hemodynamic variables. Echocardiograph
A) Preload represented by left ventricular end diastolic diameter was unc
p  0.001). (C) Heart rate increased significantly after the race (p  0.05)
E) Continuous heart rate tracing from lead competitor. bpm  beats/m
nd-diastolic diameter; MAP  mean arterial pressure.D-genotype individuals (p  0.01). These individual besults explain a significant increase in sympathovagal balance
low-frequency:high-frequency ratio) concentrated in compet-
tors with DD genotype (p  0.02). The BEI also increased
ore in this group (p  0.06).
ISCUSSION
decline in cardiac function after prolonged exercise has
een recognized for some time. Its nature, however, has
emained elusive. In the most extensive examination of this
henomenon to date, we show that a competitor’s genotype
t the ACE locus can predict the extent of their exercise
nduced decline in systolic but not diastolic function and
hat this may be explained through enhanced sympathovagal
d hemodynamic variables (n  48) before and after the race (mean  SE)
d (p  0.19). (B) Ejection fraction decreased significantly after the race
Afterload represented by mean arterial pressure did not change (p  0.52).
e; EF  ejection fraction; HR  heart rate; LVED  left ventricularic an
hange
. (D)
inutalance in DD-genotype individuals.
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ACE Genotype and Prolonged Exercise August 1, 2006:523–31The most extensive period of exercise in which cardiac
atigue has been previously studied was 24 h. Niemela et al.
32) studied 12 marathon runners who completed a 146- to
27-km race and found reversible changes in fractional
hortening and prolongation of early diastolic filling, the
atter of which correlated with the total distance covered.
owever, most studies have focused on shorter race dura-
ion. In the present study, we found a greater decline in
ystolic function that previously reported. In the Douglas
t al. (2) study, fractional shortening decreased in 21
thletes, from 39  5% to 35  5% (SD) whereas in the
hyte et al. (10) study, fractional shortening decreased
rom 40 3% to 37 2%. Over the course of 24 h (32), the
ecline was 38 5% to 32 5%. Our reduction from 40
% to 32  6% presents the intriguing question as to
hether even more prolonged exertion could result in
urther decreases in fractional shortening into the clinical
ange. Although the shape of the curve in Fig. 2B suggests
Table 3. Impedance Cardiography (n  27)
Variable Before S
RR interval (ms) 1.08 0
SV (ml) 101.5 3
SI (ml/m2) 52.4 1
CO (l/min) 5.7 0
CI, l/(min·m2) 3.0 0
TPR (dyne·s/cm5) 1536 109
LVET (ms) 0.32 0
PEP (ms) 0.11 0
RZ (ms) 0.18 0
REP (ms) 0.071 0
ZO (ohm) 31.9 0
dZ-dtmax (ohm·ms
1) 1.70 0
*Indicates a p value 0.05.
CI  cardiac index; CO  cardiac output; dZ-dtmax 
ventricular ejection time; PEP  pre-ejection period; REP 
value to dz/dtmax); RZ time interval from ECG R-wave p
index; SV  stroke volume; TPR  total peripheral resistan
igure 2. Changes in fractional shortening. (A) Four competitors were re
emonstrated. (B) Decline in fractional shortening plotted against length of rac
nd drop in fractional shortening were greater than previously reported. FS leveling of effect, in the current study, one participant’s
ractional shortening decreased dramatically, which was
ssociated with an increase in troponin in the clinical range
0.35). Investigators have previously reported isolated exam-
les of pulmonary edema in athletes (33) that are consistent
ith deficient forward flow from LV dysfunction (overhy-
ration notwithstanding) (34).
Cardiac drift describes the tendency of HR to drift
pwards during prolonged exercise (12,14,16). Debate has
een ongoing regarding the cause of this phenomenon,
hich is clearly linked to a reduction in stroke volume, with
ost suggesting it relates to changes in thermoregulation
nd specifically hyperthermia (13,15). One recent study
emonstrated a link with diastolic parameters (reduction in
:A ratio) in 16 athletes (11). However, in that study, the
xercise challenge was only 2 h and, accordingly, no systolic
ysfunction was demonstrated. Further, the presence of a
rift of 9 beats/min at constant work rate indicates that
After SEM p Value
1.06 0.04 0.60
104.9 4.3 0.42
54.5 2.1 0.32
6.1 0.31 0.21
3.2 0.16 0.16
1328 66 0.09
0.32 0.004 0.9
0.10 0.004 0.08
0.18 0.003 0.70
0.076 0.002 0.001*
29.3 0.54 0.001*
1.84 0.09 0.24
mum rate of change of thoracic impedance; LVET  left
ejection period (time interval from the opening of the aortic
maximum rate of change of thoracic impedance; SI stroke
 mean base impedance.
ed at 24 and 48 h after the race. Partial recovery of systolic function wasEM
.03
.6
.9
.21
.10
.004
.002
.003
.0009
.60
.13
maxi
rapidscann
e as reported for key studies. In the current study, the exercise challenge
fractional shortening.
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August 1, 2006:523–31 ACE Genotype and Prolonged Exerciseystolic dysfunction is not necessary to explain cardiac drift,
ut it may yet be sufficient in more prolonged exercise and
s likely contributory. In our study, we found no change in
reload, a trend toward a decrease in afterload (both of
hich alone would augment function), and a decline in
ractional shortening, all of which suggests that the increase
n HR is a compensatory measure to maintain cardiac
utput, something we observed in our study participants.
A unique aspect of our study was the investigation of
odulatory effects of the insertion deletion polymorphism
f the ACE gene on long-term cardiovascular performance.
he ability of ACE genotype to predict the extent of
xercise-induced decline in systolic LV function is a novel
nding. Despite its intronic location, the insertion allele has
een shown to be associated with a lower serum ACE
Table 4. Changes in Frequency Components o
Variable Before
BP VLFnu (%) 50.9
BP LFnu (%) 30.4
BP HFnu (%) 18.7
BP VLF (mm Hg2) 484
BP LF (mm Hg2) 380
BP HF (mm Hg2) 246
BP power (mm Hg2) 1,201
BP LF/HF (ratiometric) 2.28
HR VLFnu (%) 25.9
HR LFnu (%) 40.5
HR HFnu (%) 33.4
HR VLF (ms2) 0.11
HR LF (ms2) 0.18
HR HF (ms2) 0.16
HR Power (ms2) 0.45
HR LF/HF (ratiometric) 1.92
BRS slope total (ms/mm Hg) 19.0
BEI total (%) 13.3
*Indicates a p value 0.05.
BEI  baroreceptor effectiveness index; BP  blood pres
 heart rate; LF  low frequency; nu  units normalized t
igure 3. Effect of angiotensin-converting enzyme (ACE) genotype. Th
A, p  0.017, n  22 [ID], 11 [II], 15 [DD]). Individuals homozygous
omozygous for the deletion allele. Heterozygous individuals exhibited an inte
ypertrophy (B, p  0.8). LV  left ventricular.ctivity, which is believed to correlate with more “efficient”
uscle activity (35). As such, our findings could relate to
hanges in enzyme function (although we might expect less
efficient”—albeit skeletal—muscle to fatigue more easily).
linked possibility is that although no overrepresentation
f the I allele was found in the overall group of athletes (our
opulation was more diverse than that of Montgomery et al.
21], with some elite and some recreational athletes), the I
llele was overrepresented in the elite athletes or those
earer the front of the race. In fact, participants with the I
llele were spread throughout the rankings (data not
hown). An alternative mechanism is suggested by our
nvestigation of HR and BP variability in this population.
ympathovagal balance, although not changed after the race
n the group overall, was differentially modulated according
and BP Variability
M After SEM p Value
.1 37.6 2.3 0.001*
.1 39.2 3.3 0.07
.6 25.9 3.2 0.03*
454 50 0.66
694 111 0.03*
291 39 0.43
1,952 360 0.07
.34 2.39 0.41 0.84
.4 27.3 2.54 0.68
.2 38.0 2.4 0.50
.6 33.6 2.6 0.96
.02 0.16 0.02 0.02*
.03 0.24 0.03 0.16
.03 0.25 0.04 0.07
.06 0.68 0.1 0.04*
.37 1.56 0.21 0.42
.36 21.9 2.79 0.33
.73 19.7 1.91 0.02*
RS  buroreceptor sensitivity; HF  high frequency; HR
all power; VLF  very low frequency. (n  27).
as a differential decline in systolic function according to ACE genotype
e insertion allele exhibited greater declines in systolic function than thosef HR
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ACE Genotype and Prolonged Exercise August 1, 2006:523–31o genotype with participants homozygous for the deletion
llele exhibiting an increased sympathovagal balance not
ound in the other groups. This surprising finding suggests
greater sympathetic activation in the DD-allele partici-
ants after the race that may have served to limit the extent
f measured decline in LV systolic function. Of importance,
his observation does not speak to the level of activation
uring the race. Greater within-race activation might por-
end greater rather than lesser cardiac fatigue. In fact,
hanges in beta-adrenergic responsiveness have been sug-
ested previously in the etiology of exercise-induced LV
ysfunction. Eysmann et al. (36) demonstrated a decline in
hronotropic responsiveness in sedentary individuals and in
thletes after the Hawaii Ironman (6) (in the former study,
he change correlated with functional declines). These
igure 4. Heart rate and blood pressure (BP) variability. There was a diffe
igh-frequency (units normalized to overall power; LFnu, HFnu) compon
ympathovagal balance in participants homozygous for the deletion allele.
n these individuals in the baroreceptor effectiveness index (BEI). (D) Show
y upper tracings, blood pressure variability [BPV] by lower tracings) illus
f BPV, increase in low- and high-frequency; increase in very low frequenndings, in combination with our report, clearly implicate sifferential modulation of autonomic nervous system function
n the phenomenon of cardiac fatigue but do not preclude
lternative mechanisms, such as prolonged increased HRs,
ransient ischemia (37), or a decline in local or change in
irculating substrate (38). The relative contribution of each of
hese remains to be illuminated by future study.
onclusions. We present a comprehensive evaluation of
ardiovascular physiology in a group of athletes participating
n exercise at the limit of aerobic endurance. We confirm the
henomenon of cardiac fatigue in response to prolonged
xercise and report more extensive declines in LV function
han previously observed. In addition, we show a differential
ecline according to ACE genotype and, by demonstrating
orresponding changes in autonomic function, suggest one
ossible mechanism. Contractile failure in the context of
l effect of angiotensin-converting enzyme genotype on both the low- and
f BP variability (A and B) and an overall significant enhancement of the
addition, there was a more dramatic increase (from a lower initial value)
raw tracings for one competitor (heart rate variability [HRV] is signified
g the strongest overall signals (decrease in very low frequency component
ponent of HRV). dBP  diastolic blood pressure; RRI  R-R interval.rentia
ents o
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tratinubstrate depletion is an important phenomenon which may
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